↓ Skip to main content

Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial

Overview of attention for article published in Breast Cancer Research, January 2014
Altmetric Badge

Mentioned by

facebook
1 Facebook page

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
64 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical trial
Published in
Breast Cancer Research, January 2014
DOI 10.1186/bcr3600
Pubmed ID
Authors

Vivien HC Bramwell, Alan B Tuck, Judith-Anne W Chapman, Pieter H Anborgh, Carl O Postenka, Waleed Al-Katib, Lois E Shepherd, Lei Han, Carolyn F Wilson, Kathleen I Pritchard, Michael N Pollak, Ann F Chambers

Abstract

Osteopontin (OPN) is a malignancy-associated glycoprotein that contributes functionally to tumor aggressiveness. In metastatic breast cancer, we previously demonstrated that elevated OPN in primary tumor and blood was associated with poor prognosis.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 64 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Portugal 1 2%
Unknown 63 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 13 20%
Student > Bachelor 12 19%
Student > Master 8 13%
Student > Ph. D. Student 8 13%
Other 7 11%
Other 3 5%
Unknown 13 20%
Readers by discipline Count As %
Medicine and Dentistry 21 33%
Biochemistry, Genetics and Molecular Biology 11 17%
Agricultural and Biological Sciences 6 9%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Nursing and Health Professions 2 3%
Other 5 8%
Unknown 17 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 January 2014.
All research outputs
#22,758,309
of 25,373,627 outputs
Outputs from Breast Cancer Research
#1,882
of 2,052 outputs
Outputs of similar age
#281,358
of 320,910 outputs
Outputs of similar age from Breast Cancer Research
#23
of 28 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 320,910 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 28 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.